Microbial Protein Patents

Microbial protein patents cover strain/organism innovations; fermentation/bioreactor innovations; feedstock/gas innovations; and product/processing innovations — with IP held by food-tech, biotech, and ingredient companies and research organizations (in a field of single-cell/microbial protein). WHY MICROBIAL PROTEIN: 'MICROBIAL PROTEIN' (also SINGLE-CELL PROTEIN) is protein-rich food and feed grown from MICROORGANISMS — bacteria, fungi (including yeasts and filamentous fungi), or microalgae — instead of from animals or crops; the microbes are grown in BIOREACTORS (fermentation tanks) where they multiply rapidly on a chosen feedstock, then the biomass is harvested and processed into a protein-rich ingredient or food; what's exciting is the FEEDSTOCK options: some microbes grow on SUGARS, but others can grow on GASES — feeding HYDROGEN, CO2, and a nitrogen source (essentially making 'protein from air and electricity'), or on METHANE/CO2, or on industrial/agricultural BY-PRODUCTS; this DECOUPLES protein production from farmland and weather, can be vastly more LAND-and-water-EFFICIENT than animal agriculture, and (with gas fermentation) can even CONSUME CO2; famous examples include MYCOPROTEIN (the fungal protein in Quorn); the brutal CHALLENGES: the STRAIN/ORGANISM (the microbe — its protein content, growth rate, safety, nutrition, and taste/functionality), the FERMENTATION/BIOREACTOR (growing it efficiently at HUGE scale and LOW cost — the central cost challenge), the FEEDSTOCK/GAS (the feedstock, especially GAS FERMENTATION (H2/CO2) and its supply/cost), and the PRODUCT/PROCESSING (turning microbial biomass into appealing, nutritious, safe food — taste, texture, and regulatory approval); the make-or-break IP AREAS: the STRAIN/organism, the FERMENTATION/bioreactor, the FEEDSTOCK/gas, and the product/processing; the HARD problems: the STRAIN, FERMENTATION, FEEDSTOCK, and PRODUCT. MAJOR PLAYERS: SOLAR FOODS, AIR PROTEIN, QUORN/MARLOW, plus food and biotech companies. Strain/organism, fermentation/bioreactor, feedstock/gas, and product/processing are the core microbial-protein patent domains — and strain, fermentation, feedstock, and product are the open whitespace. (Note: microbial protein (single-cell protein) is protein-rich food/feed grown from MICROORGANISMS (bacteria/FUNGI-mycoprotein/yeast/microalgae) in BIOREACTORS instead of from animals/crops; some grow on sugars, others on GASES — H2+CO2 ('protein from air + electricity')/methane/CO2 — or by-products, decoupling protein from farmland/weather, vastly more LAND-and-water-EFFICIENT, and (gas fermentation) can consume CO2; famous example MYCOPROTEIN (Quorn); brutal challenges in the STRAIN, the FERMENTATION/BIOREACTOR (huge scale + low cost — the central challenge), the FEEDSTOCK/GAS, and the PRODUCT (taste/texture/nutrition/regulatory); biotech/process IP §101-resilient.)

Strain/organism innovations; fermentation/bioreactor innovations; mycoprotein innovations; and gas-fermentation innovations represent core microbial-protein patent domains — and the strain/organism (the protein-producing microbe) and the fermentation/bioreactor (growing it cheaply at scale) are the foundational, high-value, §101-resilient capabilities. STRAIN / ORGANISM PATENTS: the MICROBE — the protein-producing ORGANISM (the specific microbe — a BACTERIUM (e.g. hydrogen-oxidizing bacteria for gas fermentation), a FUNGUS (FILAMENTOUS FUNGI for MYCOPROTEIN — naturally meaty texture), a YEAST, or a MICROALGA), STRAIN SELECTION/ENGINEERING (selecting or engineering strains for high protein content, fast growth, efficient feedstock use, and good nutrition), PROTEIN CONTENT/NUTRITION (high-quality complete protein, vitamins, low anti-nutrients), and SAFETY (food-safe, non-toxic, non-pathogenic strains); strain methods are core, high-value, DISTINCTIVE IP, §101-resilient (the protein-producing ORGANISM/STRAIN (selection/engineering, protein content/nutrition, safety) is core, contested, defensible IP — engineered strains and novel organisms are patentable, and the strain determines protein quality, growth, and feedstock efficiency). FERMENTATION / BIOREACTOR PATENTS: the PRODUCTION — efficient FERMENTATION/BIOREACTOR DESIGN (the tanks and process for growing the microbes — for GAS FERMENTATION, special reactors that efficiently dissolve and transfer gases (H2/CO2/methane) to the microbes (gas-liquid mass transfer is a key challenge)), SCALE-UP (growing from lab to industrial volumes reliably — a major hurdle), LOW-COST CULTIVATION (cheap media, energy, and operation — the central cost driver), PRODUCTIVITY/YIELD (high biomass productivity), and CONTINUOUS PROCESSING; fermentation methods are core, high-value, DISTINCTIVE IP, §101-resilient (the FERMENTATION/BIOREACTOR (efficient design, gas-fermentation gas-transfer reactors, scale-up, low-cost cultivation, productivity) is core, contested, defensible IP, since growing the microbes efficiently at huge scale and low cost is the central make-or-break for economic microbial protein). MYCOPROTEIN PATENTS: filamentous-fungi protein with meat-like texture; mycoprotein methods are high-value IP, §101-resilient (mycoprotein (Quorn-style) has natural meaty texture — a proven, valuable microbial protein). GAS-FERMENTATION PATENTS: growing microbes on H2/CO2 or methane for 'protein from air'; gas-fermentation methods are high-value IP, §101-resilient (gas fermentation decouples protein from farmland and can consume CO2 — a distinctive opportunity, with gas-transfer the key challenge). Strain/organism, fermentation/bioreactor, mycoprotein, and gas-fermentation are the highest-value core IP because the protein-producing microbe and efficient large-scale fermentation are exactly what make microbial protein work and economic.

Feedstock/gas innovations; product/processing innovations; protein-from-air innovations; and food-texture innovations represent additional microbial-protein patent domains — and the feedstock/gas (what the microbe eats) and the product/processing (turning biomass into food people want) turn the microbe into an affordable, appealing protein. FEEDSTOCK / GAS PATENTS: the INPUT — FEEDSTOCKS (what the microbes consume — SUGARS (cheaper microbes but competes with food crops), GASES (HYDROGEN + CO2 + nitrogen — 'PROTEIN FROM AIR AND ELECTRICITY', or METHANE/CO2 — decoupling from agriculture entirely), or AGRICULTURAL/INDUSTRIAL BY-PRODUCTS (upcycling waste streams)), GAS-FERMENTATION SUPPLY (sourcing cheap renewable HYDROGEN and CO2 — the feedstock cost (especially clean H2) heavily drives economics), and FEEDSTOCK COST (minimizing the dominant feedstock cost); feedstock methods are core, high-value, DISTINCTIVE IP, §101-resilient (FEEDSTOCKS (sugars, gases (H2/CO2, methane), by-products), gas-fermentation supply, and feedstock cost are core, contested, defensible IP, since the feedstock choice/cost (especially clean hydrogen for gas fermentation) is a dominant economic and sustainability factor). PRODUCT / PROCESSING PATENTS: the FOOD — harvesting/PROCESSING the biomass (separating and drying the microbial biomass efficiently), REMOVING NUCLEIC ACIDS/OFF-FLAVORS (microbial biomass is high in RNA/nucleic acids (must be reduced for human consumption) and can have off-flavors — processing to address these is essential), TEXTURE/FUNCTIONALITY (giving the protein appealing texture (mycoprotein's fibers, or texturizing) and functional properties for food formulation), TASTE, NUTRITION (complete protein, fortification), and REGULATORY/FOOD SAFETY (novel-food approvals — a key gate); product methods are core, high-value, DISTINCTIVE IP, §101-resilient (PROCESSING (nucleic-acid/off-flavor removal, TEXTURE/functionality, taste, nutrition) is core, contested, defensible IP, since turning microbial biomass into safe, nutritious, appealing food — especially good texture and removing nucleic acids/off-flavors — is essential for consumer acceptance). PROTEIN-FROM-AIR PATENTS: gas-fermentation protein from H2/CO2/nitrogen; protein-from-air methods are high-value IP, §101-resilient ('protein from air and electricity' is microbial protein's most distinctive, land-decoupled proposition). FOOD-TEXTURE PATENTS: giving microbial protein appealing meat-like texture/functionality; food-texture methods are high-value IP, §101-resilient (texture/functionality is key to consumer acceptance and food use). Feedstock/gas, product/processing, protein-from-air, and food-texture are the highest-value IP because the feedstock (cost/sustainability) and turning biomass into appealing, safe food are exactly what make microbial protein affordable and accepted.

Microbial protein startup IP strategy must navigate the strains-and-bioreactors-are-§101-resilient-and-patentable (microbial-protein IP is biotech/process IP — engineered STRAINS, novel organisms, BIOREACTORS, fermentation processes, and food-processing methods are PATENTABLE and §101-RESILIENT — so strain, fermentation, feedstock, and product claims are strong (a key advantage)), the fermentation-cost-and-scale-up-are-the-central-economic-make-or-break (the make-or-break is producing microbial protein at LOW ENOUGH COST and LARGE ENOUGH SCALE to compete with cheap commodity proteins (soy, animal feed) — so fermentation efficiency, scale-up, and cost-reduction IP is the most commercially decisive, since cost/scale is the central barrier (many single-cell-protein ventures have failed on economics)), the gas-fermentation-protein-from-air-is-the-distinctive-but-clean-H2-dependent-frontier (GAS FERMENTATION ('protein from air' — H2 + CO2) is the most DISTINCTIVE, land-decoupled, CO2-consuming proposition — but it depends on CHEAP, clean HYDROGEN (a cost/supply dependency) and efficient gas-transfer reactors — so gas-fermentation/reactor IP is high-value and differentiating, while being realistic about the H2-cost dependency), the feedstock-choice-defines-the-cost-and-sustainability-story (the FEEDSTOCK (sugar vs gas vs waste) determines cost, sustainability, and land-decoupling — so feedstock strategy and IP is central, since it shapes both the economics and the environmental story (e.g. gas/waste decouples from agriculture; sugar competes with crops)), the mycoprotein-and-texture-are-proven-consumer-advantages (MYCOPROTEIN (filamentous fungi, e.g. Quorn) has a naturally MEATY TEXTURE and decades of consumer acceptance — so texture/mycoprotein IP is high-value, since TEXTURE and taste are what win consumers (a key advantage of fungal over single-cell bacterial protein)), the food-vs-feed-vs-ingredient-market-strategy (microbial protein can target FOOD (consumer products — higher value, harder regulatory/acceptance), animal/aquaculture FEED (large market, easier regulatory, lower price), or as an INGREDIENT (protein powder into other products) — so a startup must choose, since feed is a faster, larger near-term market while food is higher-value), the regulatory-novel-food-approval-is-a-key-gate (microbial proteins (especially novel organisms/gas-fermentation) need NOVEL-FOOD/regulatory approval (FDA GRAS, EU Novel Food) — so the regulatory path is a key gate and timeline factor, and a startup must plan for it), the nucleic-acid-and-off-flavor-processing-are-essential (microbial biomass is high in RNA/NUCLEIC ACIDS (must be reduced for human food) and can have OFF-FLAVORS — so processing IP to address these is essential for human food (a classic single-cell-protein challenge)), the incumbent-and-FTO (Solar Foods (gas-fermentation 'Solein'), Air Protein/Kiverdi, Quorn/Marlow (mycoprotein), Calysta/Unibio (methane-based), plus historical single-cell-protein players have significant IP — so a startup needs a genuinely novel strain/fermentation/feedstock/product edge, and FTO is significant), the demonstrated-cost-scale-taste-and-nutrition-decide (microbial protein is proven by demonstrated COST, SCALE, TASTE/texture, NUTRITION, and regulatory approval — so demonstrated, economically-and-sensorially-credible performance is decisive, far more than patents alone), the be-realistic-many-single-cell-protein-ventures-have-failed-on-economics (single-cell protein has a long history of techno-economic FAILURES (cost, scale, acceptance) — so be VERY realistic about economics, scale-up, and consumer acceptance), and a landscape where strain, fermentation, feedstock, and product are the durable assets; understand that fermentation cost/scale is the central make-or-break, so the durable startup IP is in the strain, low-cost scalable fermentation, feedstock (esp. gas), and product/texture — with efficient strains, cheap scalable fermentation, gas fermentation, and appealing texture often the real moat, and that §101-resilient biotech IP, demonstrated cost/scale/taste/nutrition, regulatory approval, and FTO matter as much as patents; identify whitespace in strains, fermentation/scale-up, gas fermentation, and product/texture. MICROBIAL PROTEIN STARTUP IP STRATEGY: STRAIN/ORGANISM, FERMENTATION/BIOREACTOR, FEEDSTOCK/GAS, AND PRODUCT/PROCESSING ARE THE IP: patent strains, fermentation/bioreactors, feedstock, and products — biotech/process/food claims (§101-resilient); STRAINS-AND-BIOREACTORS-ARE-§101-RESILIENT-AND-PATENTABLE: engineered STRAINS, novel organisms, BIOREACTORS, fermentation processes, food-processing methods PATENTABLE + §101-RESILIENT (strain/fermentation/feedstock/product claims strong — a key advantage); FERMENTATION-COST-AND-SCALE-UP-ARE-THE-CENTRAL-ECONOMIC-MAKE-OR-BREAK: produce at LOW ENOUGH COST + LARGE ENOUGH SCALE to compete with cheap commodity proteins (soy/animal feed) — fermentation efficiency/scale-up/cost-reduction IP the most commercially decisive (cost/scale the central barrier — many single-cell-protein ventures failed on economics); GAS-FERMENTATION-PROTEIN-FROM-AIR-IS-THE-DISTINCTIVE-BUT-CLEAN-H2-DEPENDENT-FRONTIER: GAS FERMENTATION ('protein from air' — H2+CO2) the most DISTINCTIVE land-decoupled CO2-consuming proposition — but depends on CHEAP clean HYDROGEN (cost/supply dependency) + efficient gas-transfer reactors — gas-fermentation/reactor IP high-value + differentiating (be realistic about H2-cost dependency); FEEDSTOCK-CHOICE-DEFINES-THE-COST-AND-SUSTAINABILITY-STORY: the FEEDSTOCK (sugar vs gas vs waste) determines cost/sustainability/land-decoupling — feedstock strategy + IP central (shapes economics + environmental story); MYCOPROTEIN-AND-TEXTURE-ARE-PROVEN-CONSUMER-ADVANTAGES: MYCOPROTEIN (filamentous fungi — Quorn) has a naturally MEATY TEXTURE + decades of acceptance — texture/mycoprotein IP high-value (texture + taste win consumers — fungal advantage over single-cell bacterial); FOOD-VS-FEED-VS-INGREDIENT-MARKET-STRATEGY: target FOOD (consumer — higher value/harder regulatory-acceptance)/animal-aquaculture FEED (large/easier regulatory/lower price)/INGREDIENT (protein powder) — choose (feed a faster larger near-term market, food higher-value); REGULATORY-NOVEL-FOOD-APPROVAL-IS-A-KEY-GATE: novel organisms/gas-fermentation need NOVEL-FOOD/regulatory approval (FDA GRAS/EU Novel Food) — a key gate + timeline factor (plan for it); NUCLEIC-ACID-AND-OFF-FLAVOR-PROCESSING-ARE-ESSENTIAL: biomass high in RNA/NUCLEIC ACIDS (reduce for human food) + can have OFF-FLAVORS — processing IP essential for human food (a classic single-cell-protein challenge); INCUMBENT-AND-FTO: Solar Foods (gas-fermentation 'Solein')/Air Protein-Kiverdi/Quorn-Marlow (mycoprotein)/Calysta-Unibio (methane) + historical single-cell-protein players with significant IP — need a genuinely novel strain/fermentation/feedstock/product edge + FTO significant; DEMONSTRATED-COST-SCALE-TASTE-AND-NUTRITION-DECIDE: proven by COST/SCALE/TASTE-texture/NUTRITION/regulatory approval — demonstrated economically-and-sensorially-credible performance decisive (far more than patents); BE-REALISTIC-MANY-SINGLE-CELL-PROTEIN-VENTURES-HAVE-FAILED-ON-ECONOMICS: long history of techno-economic FAILURES (cost/scale/acceptance) — be VERY realistic about economics/scale-up/consumer acceptance; §101-RESILIENT-BIOTECH/COST-SCALE-TASTE-NUTRITION/REGULATORY/FTO MATTER AS MUCH AS PATENTS: §101-resilient biotech IP, demonstrated cost/scale/taste/nutrition, regulatory approval, and FTO drive value; WHEN TO PATENT: NOVEL STRAIN/FERMENTATION/FEEDSTOCK/PRODUCT WITH DATA: file once it shows data (strain protein/growth + fermentation productivity/scale/cost + feedstock/gas-transfer + product taste/texture/nutrition) — biotech/process/food claims (strains as compositions); demonstrated cost, scale/productivity, taste/texture, nutrition, and regulatory approval are the critical microbial-protein IP metrics; KEY FTO CHECKLIST: Solar Foods/Air Protein-Kiverdi/Quorn-Marlow/Calysta-Unibio + historical single-cell-protein players; strain/organism (protein-producing ORGANISM-bacteria-FUNGI-mycoprotein-yeast-microalgae/strain selection-engineering/protein content-nutrition/safety — §101-resilient, the microbe); fermentation/bioreactor (FERMENTATION-BIOREACTOR design/scale-up/low-cost cultivation/gas-fermentation gas-transfer reactors/productivity-yield/continuous — §101-resilient, the production); mycoprotein (meaty texture); gas-fermentation (protein from air, gas-transfer the challenge); feedstock/gas (FEEDSTOCKS-sugars-GASES-H2-CO2-methane-by-products/gas-fermentation supply-clean-H2/feedstock cost — §101-resilient, the input); product/processing (harvesting-PROCESSING/remove NUCLEIC ACIDS-off-flavors/TEXTURE-functionality/taste/nutrition/regulatory-food-safety — §101-resilient, the food); protein-from-air (the distinctive proposition); food-texture (consumer acceptance); strains + bioreactors §101-resilient + patentable; fermentation cost + scale-up the central economic make-or-break; gas-fermentation protein-from-air the distinctive but clean-H2-dependent frontier; feedstock choice defines the cost + sustainability story; mycoprotein + texture proven consumer advantages; food vs feed vs ingredient market strategy; regulatory novel-food approval a key gate; nucleic-acid + off-flavor processing essential; incumbent + FTO; demonstrated cost + scale + taste + nutrition decide; be realistic — many single-cell-protein ventures failed on economics.